参考文献/References:
[1] PHELAN A L, KATZ R, GOSTIN L O. The novelcoronavirus originating in Wuhan, China: challengesfor global health governance[J]. the Journal of theAmerican Medical Association, 2020, 323(8): 709-710.
[2] FORNI D, CAGLIANI R, CLERICI M, et al. Molecularevolution of human coronavirus genomes[J]. Trends inMicrobiology, 2017, 25(1): 35-48.
[3] LU Hongzhou, STRATTON C W, TANG Yiwei.Outbreak of pneumonia of unknown etiology in Wuhan,China: The mystery and the miracle[J]. Journal ofMedical Virology, 2020, 92(4): 401-402.
[4] CHEN Nanshan, ZHOU Min, DONG Xuan, et al.Epidemiological and clinical characteristics of 99 cases of2019 novel coronavirus pneumonia in Wuhan, China: adescriptive study[J]. Lancet, 2020, 395(1223): 507-513.
[5] 中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案( 试行第七版) [EB/OL ]. (2020-03-04). [2020-03-05 ].http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. General Office of National Health Commission ofthe People’s Republic of China, Office of NationalAdministration of Traditional Chinese Medicine.Diagnosis and treatment of corona virus disease-19 (7thtrial edition) [EB/OL ]. (2020-03-04). [2020-03-05].http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[6] HUANG Chaolin, WANG Yeming, LI Xingwang, etal. Clinical features of patients infected with 2019novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(1223): 497-506.
[7] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎诊疗方案（试行第五版修订版）[EB/OL]. （2020-02-08） [2020-02-23].http//www.nhc.gov.cn/xcs/zhengcwj/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf. General Office for National Health Commission. Theguideline of diagnosis and treatment of COVID-19（Pilot Release 5 Revision）[EB/OL].（2020-02-08）[2020-02-23]. http：//www.nhc.gov.cn/xcs/zhengcwj/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf.
[8] WANG Chen,HORBY P W,HAYDEN F G, et al. Anovel coronavirus outbreak of global health concern[J].Lancet (London, England),2020,395(10223): 470-473.
[9] 莫茜，秦炜，傅启华, 等. 正确认识新型冠状病毒核酸检测的影响因素[J]. 中华检验医学杂志,2020,43（3）:213-216． MO Xi,QIN Wei,FU Qihua,et al. Understanding theinfluence factors in viral nucleic acid test of 2019novel coronavirus[J]. Chinese Journal of LaboratoryMedicine, 2020,43（3）:213-216．[10] ZHOU Peng， YANG Xinglou， WANG Xianguang，et al. Discovery of a novel coronavirus associatedwith the recent pneumonia outbreak in humans and itspotential bat origin[J]. bioRxiv,（2020-01-23）.doi:https://doi.org/10.1101/2020.01.22.914952.
[11] World Health Organization . Clinical management ofsevere acute respiratory infection when novel coronavirus(nCoV) infection is suspected[EB/OL]. （2020-01-11）https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.
[12] SHAO Xiuping, GUO Xiaojie, ESPER F, et al.Seroepidemiology of group I human coronaviruses inchildren[J]. Journal of Clinical Virology, 2007, 40(3):207-213.
[13] CHAN K H, CHAN J F, TSE H, et al. Cross-reactiveantibodies in convalescent SARS patients’ seraagainst the emerging novel human coronavirus EMC(2012) by both immunofluorescent and neutralizingantibody tests[J]. The Journal of Infection, 2013,67(2): 130-140.
[14] DIJKMAN R, JEBBINK M F, GAUNT E, et al. Thedominance of human coronavirus OC43 and NL63infections in infants[J]. Journal of Clinical Virology,2012, 53(2): 135-139.
[15] SUN Z F, MENG X J. Antigenic cross-reactivitybetween the nucleocapsid protein of severe acuterespiratory syndrome (SARS) coronavirus andpolyclonal antisera of antigenic group I animalcoronaviruses: Implication for SARS diagnosis[J].Journal of Clinical Microbiology, 2004, 42(5): 2351-2352.
[16] WOO P Y, LAU S P, WONG B L, et al. False-Positiveresults in a recombinant severe acute respiratorySyndrome-Associated coronavirus (SARS-CoV)nucleocapsid Enzyme-Linked immunosorbent assaydue to HCoV-OC43 and HCoV-229E rectified bywestern blotting with recombinant SARS-CoV spikepolypeptide[J]. Journal of Clinical Microbiology, 2004,42(12): 5885-5888.
[17] AN Jianghong, LIAO Xuejiao, XIAO Tongyang,et al.Clinical characteristics of the recovered COVID-19patients with re-detectable positive RNA test[J].medRxiv, （2020-03-30）.doi: https://doi.org/10.1101/2020.03.26.20044222.
相似文献/References:
[1]童 伟,陈登奕,陈俊文,等.2019-nCoV 总抗体两种免疫学检测方法的应用评价[J].现代检验医学杂志,2020,35(02):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
TONG Wei,CHEN Deng-yi,CHEN Jun-wen,et al.Application Evaluation of Two Immunological Detection Methodsof 2019-nCoV Specific Antibodies[J].Journal of Modern Laboratory Medicine,2020,35(04):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
[2]谢 辉,刘玮玮b,郭 娟a,等.新型冠状病毒肺炎疫情下检验医学临床服务管理的探索[J].现代检验医学杂志,2020,35(03):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
XIE Huia,LIU Wei-weib,GUO Juana,et al.Exploration on Clinical Service Management of Laboratory Medicine
during COVID-19 Epidemic Period[J].Journal of Modern Laboratory Medicine,2020,35(04):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
[3]陈泽衍,马 雯,张立俊,等.荧光免疫层析法检测全血2019-nCoV IgM 和IgG 抗体在新型冠状病毒肺炎诊断中的应用[J].现代检验医学杂志,2020,35(03):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
CHEN Ze-yan,MA Wen,ZHANG Li-jun,et al.Application of 2019-nCoV IgM and IgG Tests by Fluorescence
Immunochromatography in the Diagnosis of 2019-nCoV Infections[J].Journal of Modern Laboratory Medicine,2020,35(04):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
[4]朱传新,周玉平,何 艳,等.92 例新冠肺炎病毒感染患者早期外周血白细胞形态分析[J].现代检验医学杂志,2020,35(03):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
ZHU Chuan-xin,ZHOU Yu-ping,HE Yan,et al.Morphological Analysis of Early Peripheral Blood Leukocytes in 92 Patients
with New Coronary Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(04):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
[5]刘艳霞,区静怡,黄 颖,等.新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义[J].现代检验医学杂志,2020,35(04):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
LIU Yan-xia,OU Jing-yi,HUANG Ying,et al.Clinical Significance of Detection of Peripheral Blood Lymphocyte and Its Subgroups in Patients with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(04):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
[6]佟 丽,黄丽萍,石晓霞,等.血栓弹力图检测新型冠状病毒肺炎患者凝血功能的探讨分析[J].现代检验医学杂志,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
TONG Li,HUANG Li-ping,SHI Xiao-xia,et al.Investigation and Analysis of Thromboelastography in the Detection of COVID-19 Patients[J].Journal of Modern Laboratory Medicine,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
[7]胡纪文,王恩运,阚丽娟,等.三种化学发光法检测新型冠状病毒（SARS-CoV-2）抗体试剂盒的临床应用评价[J].现代检验医学杂志,2020,35(04):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
HU Ji-wen,WANG En-yun,KAN Li-juan,et al.Evaluation of Clinical Application of Three Chemiluminescence Detection Kits for Detection of Novel Coronavirus (SARS-CoV-2) Antibody[J].Journal of Modern Laboratory Medicine,2020,35(04):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
[8]白欢,沈玲,袁旭,等.新型冠状病毒肺炎患者早期外周血实验室检查结果分析[J].现代检验医学杂志,2020,35(05):93.[doi:10.3969/j.issn.1671-7414.2020.05.024]
BAI Huan,SHEN Ling,YUAN Xu,et al.Analysis of the Characteristics of Hematological Parameters in the Early
Stages of COVID-19[J].Journal of Modern Laboratory Medicine,2020,35(04):93.[doi:10.3969/j.issn.1671-7414.2020.05.024]
[9]闫美田,郑雨桐,孙艳美,等.新型冠状病毒肺炎患者血液CRP, CREA, ALB, IL-6 水平检测对疾病预后的应用价值分析[J].现代检验医学杂志,2020,35(05):106.[doi:10.3969/j.issn.1671-7414.2020.05.027]
YAN Mei-tian,ZHENG Yu-tong,SUN Yan-mei,et al.Analysis of the Value of Detection of Blood CRP,CREA,ALB and IL-6 Level
in Patients with New Coronavirus Pneumonia to the Prognosis of the Disease[J].Journal of Modern Laboratory Medicine,2020,35(04):106.[doi:10.3969/j.issn.1671-7414.2020.05.027]
[10]王琳琳a,张晓凝,王刚b,等.外周血白细胞参数对于新型冠状病毒肺炎诊断的临床意义[J].现代检验医学杂志,2020,35(05):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]
WANG Lin-lina,ZHANG Xiao-ning,WANG Gangb,et al.Clinical Significance of Peripheral Blood Leukocyte Parameters in the
Diagnosis of COVID-19[J].Journal of Modern Laboratory Medicine,2020,35(04):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]
[11]张园,周泽奇,王志贤,等.新型冠状病毒核酸、抗原和抗体联合检测的临床价值讨论[J].现代检验医学杂志,2020,35(05):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
ZHANG Yuan,ZHOU Ze-qi,WANG Zhi-xian,et al.Discussion on the Clinical Value of Combined Detection of SARS-CoV-2
Nucleic Acid，Antigen and Antibody[J].Journal of Modern Laboratory Medicine,2020,35(04):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
[12]陈赛,刘海艇,李铁,等.新型冠状病毒肺炎患者肝功能异常的相关临床分析[J].现代检验医学杂志,2020,35(05):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
CHEN Sai,LIU Hai-ting,LI Tie,et al.Clinical Analysis of Abnormal Liver Function in Patients with New
Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(04):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
[13]宁明哲,陶 月,陈雨欣,等.新型冠状病毒血清特异性抗体检测的假性问题分析和对策探讨[J].现代检验医学杂志,2020,35(06):129.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]
NING Ming-zhe,TAO Yue,CHEN Yu-xin,et al.SARS-CoV-2 Serological Antibody Testing: Problems of FalseDetections and the Solutions[J].Journal of Modern Laboratory Medicine,2020,35(04):129.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]
[14]孟凡萍,郝 坡.新型冠状病毒肺炎患者外周血淋巴细胞亚群的分析研究[J].现代检验医学杂志,2021,36(02):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
MENG Fan-ping,HAO Po.Analysis of Peripheral Blood Lymphocyte Subsets in Patients with Novel Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2021,36(04):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
[15]吴永彬,李 凌.CRISPR/Cas系统在新型冠状病毒肺炎快速诊断中的应用[J].现代检验医学杂志,2022,37(03):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]
WU Yong-bin,LI Ling.Application of CRISPR/Cas Systems in the Rapid Diagnosis of Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]